MARK Anticorpi
| Empty Table Header | Nome del prodotto | CATALOG # | Isotipo | Epitopo | Applicazione | Species | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|---|
MARK2 Anticorpo (B-1) | sc-365405 | mouse IgG1 κ | 416-501 (h) | WB, IP, IF, ELISA | h | 2 | ||
MARK3 Anticorpo (F-6) | sc-376116 | mouse IgG1 κ | 447-501 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
MARK3 Anticorpo (G-11) | sc-365461 | mouse IgG3 κ | 12-39 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
MARK3 Anticorpo (G-7) | sc-376115 | mouse IgG2a κ | 447-501 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new |
MARK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
MARK1 Plasmide KO CRISPR/Cas9 (h) | sc-404508 | h | Gene Knockout | GFP | 0 | ||
MARK1 Plasmide HDR (h) | sc-404508-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MARK2 Plasmide KO CRISPR/Cas9 (h) | sc-403714 | h | Gene Knockout | GFP | 1 | ||
MARK2 Plasmide HDR (h) | sc-403714-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
MARK2 Plasmide Double Nickase (h) | sc-403714-NIC | h | Gene Knockout | Puromycin | 1 | ||
MARK2 Plasmide Double Nickase (h2) | sc-403714-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
MARK3 Plasmide KO CRISPR/Cas9 (h) | sc-406362 | h | Gene Knockout | GFP | 0 |
MARK CRISPR Activation Products
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
MARK4 Plasmide di attivazione CRISPR (h) | sc-404386-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 |
MARK siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
MARK1 siRNA (h) | sc-75749 | h | Gene Silencing | N/A | 0 | ||
MARK1 Plasmide shRNA (h) | sc-75749-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK1 shRNA (h) Particelle lentivirali | sc-75749-V | h | Gene Silencing | Puromycin | 0 | ||
MARK1 siRNA (m) | sc-75750 | m | Gene Silencing | N/A | 0 | ||
MARK1 Plasmide shRNA (m) | sc-75750-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK1 shRNA (m) Particelle lentivirali | sc-75750-V | m | Gene Silencing | Puromycin | 0 | ||
MARK2 siRNA (h) | sc-45793 | h | Gene Silencing | N/A | 0 | ||
MARK2 Plasmide shRNA (h) | sc-45793-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK2 shRNA (h) Particelle lentivirali | sc-45793-V | h | Gene Silencing | Puromycin | 0 | ||
MARK2 siRNA (m) | sc-45794 | m | Gene Silencing | N/A | 0 | ||
MARK2 Plasmide shRNA (m) | sc-45794-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK2 shRNA (m) Particelle lentivirali | sc-45794-V | m | Gene Silencing | Puromycin | 0 | ||
MARK3 siRNA (h) | sc-43649 | h | Gene Silencing | N/A | 0 | ||
MARK3 Plasmide shRNA (h) | sc-43649-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK3 shRNA (h) Particelle lentivirali | sc-43649-V | h | Gene Silencing | Puromycin | 0 | ||
MARK3 siRNA (m) | sc-60087 | m | Gene Silencing | N/A | 0 | ||
MARK3 Plasmide shRNA (m) | sc-60087-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK3 shRNA (m) Particelle lentivirali | sc-60087-V | m | Gene Silencing | Puromycin | 0 | ||
MARK4 siRNA (h) | sc-97671 | h | Gene Silencing | N/A | 0 | ||
MARK4 Plasmide shRNA (h) | sc-97671-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK4 shRNA (h) Particelle lentivirali | sc-97671-V | h | Gene Silencing | Puromycin | 0 | ||
MARK4 siRNA (m) | sc-149275 | m | Gene Silencing | N/A | 0 | ||
MARK4 Plasmide shRNA (m) | sc-149275-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK4 shRNA (m) Particelle lentivirali | sc-149275-V | m | Gene Silencing | Puromycin | 0 |